Home / Articles / Molecular structure, thermal, and antimicrobial properties of dipropyl [hydroxy(aryl)methyl]phosphonates

Molecular structure, thermal, and antimicrobial properties of dipropyl [hydroxy(aryl)methyl]phosphonates

K. A. Ivshin 2, 
K. A. Ivshin
M. P. Shulaeva 3, 
M. P. Shulaeva
T. T. Senchenko 1, 
T. T. Senchenko
Published 29 September 2026 , received 25 May 2026
Communication
0
Cite this
GOST
 | 
Cite this
GOST
Davletshin R. R. et al. Molecular structure, thermal, and antimicrobial properties of dipropyl [hydroxy(aryl)methyl]phosphonates // Mendeleev Communications. 2026.
GOST all authors (up to 50)
Davletshin R. R., Sedov A. N., Ivshin K. A., Shulaeva M. P., Gerasimov A. V., Davletshina N. V., Senchenko T. T., Kuryntseva P. A. Molecular structure, thermal, and antimicrobial properties of dipropyl [hydroxy(aryl)methyl]phosphonates // Mendeleev Communications. 2026.
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.71267/mencom.8102
UR - https://mendcomm.colab.ws/publications/10.71267/mencom.8102
TI - Molecular structure, thermal, and antimicrobial properties of dipropyl [hydroxy(aryl)methyl]phosphonates
T2 - Mendeleev Communications
AU - Davletshin, R. R.
AU - Sedov, A. N.
AU - Ivshin, K. A.
AU - Shulaeva, M. P.
AU - Gerasimov, A. V.
AU - Davletshina, N. V.
AU - Senchenko, T. T.
AU - Kuryntseva, P. A.
PY - 2026
DA - 2026/09/29
PB - Mendeleev Communications
ER -
BibTex
Cite this
BibTex (up to 50 authors)
@article{2026_Davletshin,
author = {R. R. Davletshin and A. N. Sedov and K. A. Ivshin and M. P. Shulaeva and A. V. Gerasimov and N. V. Davletshina and T. T. Senchenko and P. A. Kuryntseva},
title = {Molecular structure, thermal, and antimicrobial properties of dipropyl [hydroxy(aryl)methyl]phosphonates},
journal = {Mendeleev Communications},
year = {2026},
publisher = {Mendeleev Communications},
month = {Sep},
url = {https://mendcomm.colab.ws/publications/10.71267/mencom.8102},
doi = {10.71267/mencom.8102}
}
Views / Downloads
44 / 13

Abstract

The molecular structures, thermal decomposition behavior, and antimicrobial activity of dipropyl α‑hydroxy(aryl)methylphosphonates were investigated. It was shown that the nature of the para-substituent dictated the crystal packing via a hierarchy of secondary interactions, whereas thermal degradation correlated with the nature of the substituent on the benzene ring. All compounds exhibited antimicrobial activity against B. cereus and S. aureus comparable to that of benzalkonium chloride, as well as activity against Candida fungi.

Keywords

Abramov reaction
antimicrobial activity
molecular structure
thermal stability
α-hydroxyphosphonates

Communication

Among organophosphorus compounds, α‑hydroxyalkylphosphonates are recognized for their good chemical stability and favorable bioavailability. In recent years, they have attracted growing research interest due to their antimicrobial, antioxidant, herbicidal, anticancer, anti‑HIV, and anti‑inflammatory properties.[1-6] Their ability to suppress the growth of bacteria, fungi, and viruses stems mainly from the inhibition of essential microbial enzymes or interference with metabolic and structural pathways.[7-12] Consequently, α‑hydroxyphosphonates are considered promising scaffolds for the development of new antibiotics, especially in the context of increasing resistance to conventional drugs.[13-18] The simultaneous presence of a phosphonate moiety and an α‑hydroxyl group allows these compounds to interact with key metabolic enzymes and cellular membranes, thereby disrupting the metabolism of pathogenic cells.[19-27]

X‑ray structures of numerous α‑hydroxyphosphonate derivatives were reported.[28-30] It was shown that the presence of a tertiary α‑carbon atom or a sterically and electronically shielded α‑CH proton favored dimer formation.[31] Additionally, the type and degree of crowding of ortho-substituents on the aromatic ring determined whether chains or dimers were formed.

In our previous work, we investigated the structure, properties, and biological activity of α‑bromocinnamaldehyde derivatives.[32] The present study follows this research by focusing on phosphonate derivatives. Detailed knowledge of the regularities that govern the association of molecules in the solid state and lead to the formation of ordered crystalline architectures provides valuable information on molecular geometry, intermolecular contacts, and electronic characteristics. Simultaneous investigation of crystal structure and antimicrobial properties is important not only for establishing structure–activity relationships but also for practical applications. These include the development of solid dosage forms, bioavailability assessment (considering solubility and polymorphism), as well as storage stability and analytical identification.

α‑Hydroxy(aryl)methylphosphonates 1–3 were chosen for the studies. Of note, short alkyl chain (namely, n-propyl) esters was envisioned to impart sufficient water solubility of the target molecules, and hence enable antimicrobial testing in aqueous media. Target products 1–3 were obtained via the Abramov reaction from the corresponding aldehydes (Scheme 1).[32-35] The transformation was completed within 0.5 h under solvent-free conditions affording α‑hydroxymethylphosphonates 1–3 in excellent yields.

Scheme 1
Reagents and conditions: i, K3PO4 (10 mol%), solvent free, room temperature, 30 min.

The molecular structures of all compounds were confirmed by a combination of spectroscopic methods and single-crystal X-ray diffraction (Figure 1, see also Online Supplementary Materials).† Reasonably, 1H and 13C NMR spectra showed non‑equivalency of the two propoxy groups. Characteristic signals included the P–CH proton as a doublet at ~4.9 ppm and the P–CH carbon as a doublet at ~70 ppm (1JP–C ≈ 160 Hz). The OH proton was observed only for compound 1 (~4.3 ppm), whereas for 2 and 3 it was absent due to fast exchange. Characteristic ν(=C–H) and ν(C=C) bands in the FTIR spectra were in accordance with literature data.[36]Of special importance were broad ν(OH) band at 3100–3300 cm–1 as well as ν(P=O) band diminished and downshifted to ~1206–1230 cm–1, that evidenced about intermolecular O–H···O=P hydrogen bonding. This H-bonding was also confirmed by the X‑ray diffraction analysis.

Figure 1
Molecular structures of compounds (a) 1, (b) 2, and (c) 3.

For compounds 1 and 3 (in contrast to bromine‑substituted derivative 2), the dominant supramolecular motif was a one‑dimensional chain formed by classical O–H···O hydrogen bonds (Table S2). Despite this common feature, the three‑dimensional packing differed markedly depending on the para-substituent. The chlorine derivative crystallized in the orthorhombic space group Pbca with one molecule in the asymmetric part. Molecules of the same chirality were linked into chains along the 21 screw axis (parallel to the b‑axis). These chains were connected by non‑classical C–H···O hydrogen bonds and Cl···H contacts to form columns, which were further stabilized by H···H interactions, while the chlorine atoms were oriented toward the hydrophobic region (see Figure S2).

In contrast, replacing chlorine with bromine substantially altered the intermolecular interactions and crystal packing.

Compound 2 crystallized in the monoclinic space group C2/c with four crystallographically independent molecules forming two hydrogen‑bonded dimers. These dimers were reinforced by C–H···O contacts and linked through type‑I Br···Br halogen interactions into dimeric chains. The chains further assembled into columns via Br···H, C–H···O, and C–H···π interactions (see Figure S3). Notably, Br···Br contacts are unique to the propyl esters derivative and are absent in the corresponding ethyl and isopropyl analogues.[37, 38]

Introduction of the bulky dimethylamino group in compound 3 resulted in crystallization of an enantiomerically pure S‑isomer. As in compound 1, the primary packing motif consisted of O–H···O hydrogen-bonded chains. A second, perpendicular chain system was generated by C–H···O interactions between a methyl group of the NMe2 substituent and the phosphoryl oxygen atom; propagating along the b and c axes (see Figure S4). The observed competition between chain‑linked and dimeric supramolecular motifs in compounds 1–3 is consistent with literature data on α‑aryl‑α‑hydroxyphosphonates, where the packing mode was governed by the nature and steric demand of substituents.[7, 11]

Thermal stability is an important parameter for compounds with potential antimicrobial applications, as it influences their handling, storage, and formulation. The DSC curves of all synthesized phosphonates 1–3 exhibited distinct endothermic melting peaks (see Online Supplementary Materials). No significant mass loss occurs below 150 °C, indicating the absence of volatile impurities or residual solvents (e.g., water). Above this temperature, mass loss corresponds to thermal decomposition. Table 1 provides details on the thermal stability of compounds 1–3, including the initial degradation temperature (Tonset), maximum degradation temperature (Tmax) and mass loss [∆m (%)].

Table 1
\[ \]
TG-DSC data for products 1–3.
(1)

Under an argon atmosphere, all three compounds begin to decompose in the temperature range 173–201 °C. The onset of decomposition is attributed to the cleavage of the propyl group from the phosphorus atom, which is consistent with the known lower thermal stability of the P–O–C bond at lower temperatures compared to other bonds in the molecule.[39-41]

For the halogenated derivatives 1 and 2, a single complex decomposition peak is observed in the range 174–276 °C, with a total mass loss of 65–69% (see Online Supplementary Materials). This behaviour was attributed to the simultaneous cleavage of both propyl group and the P–C–C(aromatic) bond.[28, 40] The electron‑withdrawing nature of chlorine and bromine reduces the electron density in the benzene ring, weakening the C–C bond at the ipso position and thereby facilitating the simultaneous elimination of the propyl and aromatic fragments.

Compound 3 showed the most pronounced stepwise decomposition. An initial mass loss of 13.7% occurred at an onset temperature of 133 °C, corresponding to the elimination of one propyl group. A second mass loss at higher temperature (up to 208 °C) was assigned to the loss of the second propyl group. The P–C–C(aromatic) bond cleaved only above 263 °C, with a total mass loss of 26.9% by 400 °C. Interestingly, decomposition was not complete at 400 °C. We hypothesized that the loss of the first propyl group resulted in the formation of the phosphonic monoester that can form a stabilizing hydrogen bond with a dimethylamino group (e.g., Me2N···H–O–P), thus reducing the degradation rate. This hypothesis was supported by an exothermic event in the DSC curve, indicating a thermodynamically favorable process with energy release.

The in vitro antimicrobial activity of α‑hydroxyphosphonates 1–3 was assessed against a panel of opportunistic pathogens using the agar well diffusion method. The growth inhibition zones were measured to evaluate both bactericidal and fungicidal effects. All tests were carried out using 1% ethanol solutions, and the results are summarized in Table 2. Ethanol alone produced no inhibition zones.

Table 2
\[ \]
Antimicrobial activity of compounds 1–3.
(2)

All tested compounds were practically inactive against the gram‑negative bacteria E. coli and P. aeruginosa. Weak to moderate activity was observed against the gram‑positive strains B. cereus and S. aureus. The nature of the substituent on the benzene ring has no pronounced influence on the antimicrobial potency. Overall, compounds 1–3 exhibited antibacterial activity comparable to that of commercial benzalkonium chloride. Antifungal activity against Candida species was comparable to that of the naftifine hydrochloride. It was also noted in the literature that gram‑positive bacteria were more sensitive to α‑hydroxyphosphonate derivatives than gram‑negative bacteria. Some of phosphonates also exhibited pronounced antifungal activity, which overall indicates the promise of the α‑hydroxyphosphonate scaffold for the development of antimicrobial agents.[42, 43]

In conclusion, we demonstrated a facile and environmentally friendly solvent-free synthesis of dipropyl α-hydroxy(aryl)methylphosphonates via the Abramov reaction. The crystallographic analysis of the products revealed a one-dimensional chain formed by O–H···O hydrogen bonds as the primary supramolecular motif, while the nature of the substituent on the benzene ring dramatically influenced the higher‑order crystal packing. Thermal decomposition behaviour, studied by TG‑DSC, correlated with the electronic nature of the substituent on the benzene ring. All compounds displayed antibacterial activity against the gram‑positive bacteria B. cereus and S. aureus comparable to that of benzalkonium chloride, as well as moderate fungicidal activity against Candida species. We hope this work provide a solid foundation for the design of readily accessible candidates for antimicrobial drugs based on α‑hydroxyalkylphosphonates.

«This work/publication was funded by a grant from the Academy of Sciences of the Republic of Tatarstan provided to higher education institutions, scientific and other organizations to support human resource development plans in terms of encouraging their research and academic staff to defend doctoral dissertations and conduct research activities (Agreement No. 12/2025-PD-KFU dated December 22, 2025)».

Crystal data

† Crystal data for 1. C13H20ClO4P (M = 306.71 g mol–1), orthorhombic, space group Pbca at 273(2) K: a = 15.689(3), b = 8.3013(14) and c = 24.902(5) Å, V = 3243.3(10) Å3, dcalc = 1.256 g cm–3, μ(MoKα) = 0.340 mm–1, F(000) = 1296. A total of 58837 reflections were collected (3157 independent reflections and 1937 observed reflections, Rint = 0.1243), GOOF 1.084, final R indices [I > 2σ(I )]: R1 = 0.1058, wR2 = 0.2525, R indices (all data): R1 = 0.1625, wR2 = 0.3054. Crystal data for 2. C13H20BrO4P (M = 351.17 g mol–1), monoclinic, space group C2/c at 100(2) K: a = 44.950(5), b = 10.3162(11) and c = 33.069(3) Å, β = 124.806(3)°, V = 12591(2) Å3, dcalc = 1.478 g cm–3, μ(MoKα) = 2.720 mm–1, F(000) = 5728. A total of 286259 reflections were collected (12342 independent reflections and 7856 observed reflections, Rint = 0.1597), GOOF 1.054, final R indices [I > 2σ(I )]:

Funders

Ministry of Education and Science of the Russian Federation
12/2025-PD-KFU

References

2.
Green syntheses of potentially bioactive α-hydroxyphosphonates and related derivatives
Kiss N.Z., Rádai Z., Keglevich G.
Phosphorus, Sulfur and Silicon and the Related Elements , 2019
5.
Synthesis of α ‐Hydroxyphosphonates Containing Functionalized 1,2,3‐Triazoles
Lima Y.R., Da Costa G.P., Xavier M.C., De Moraes M.C., Barcellos T., Alves D., Silva M.S.
ChemistrySelect , 2020
7.
New hybrid transition state analog inhibitors of HIV protease with peripheric C2-symmetry
Stowasser B., Budt K., Jian-Qi L., Peyman A., Ruppert D.
Tetrahedron Letters , 1992
8.
Synthesis, in vitro antibacterial and antifungal evaluations of new alpha-hydroxyphosphonate and new alpha-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline.
Kategaonkar A.H., Pokalwar R.U., Sonar S.S., Gawali V.U., Shingate B.B., Shingare M.S.
European Journal of Medicinal Chemistry , 2010
9.
Synthesis of α-Hydroxyphosphonates and Their Antioxidant Properties
Naidu K.R., Kumar K.S., Arulselvan P., Reddy C.B., Lasekan O.
Archiv der Pharmazie , 2012
10.
Green synthesis and cytotoxic activity of dibenzyl α-hydroxyphosphonates and α-hydroxyphosphonic acids
Rádai Z., Szeles P., Kiss N.Z., Hegedűs L., Windt T., Nagy V., Keglevich G.
Heteroatom Chemistry , 2018
12.
Aryl group – a leaving group in arylphosphine oxides
Stankevič M., Pisklak J., Włodarczyk K.
Tetrahedron , 2016
13.
Fosfomycin and nitrofurantoin: classic antibiotics and perspectives
dos Santos C., dos Santos L.S., Franco O.L.
Journal of Antibiotics , 2021
14.
Genomics-enabled discovery of phosphonate natural products and their biosynthetic pathways
Ju K., Doroghazi J.R., Metcalf W.W.
Journal of Industrial Microbiology and Biotechnology , 2014
15.
Fosmidomycin biosynthesis diverges from related phosphonate natural products
Parkinson E.I., Erb A., Eliot A.C., Ju K., Metcalf W.W.
Nature Chemical Biology , 2019
16.
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa H., Wiesner J., Sanderbrand S., Altincicek B., Weidemeyer C., Hintz M., Türbachova I., Eberl M., Zeidler J., Lichtenthaler H.K., Soldati D., Beck E.
Science , 1999
17.
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities
Knak T., Abdullaziz M.A., Höfmann S., Alves Avelar L.A., Klein S., Martin M., Fischer M., Tanaka N., Kurz T.
Pharmaceuticals , 2022
18.
Modified Dosing Schedule Efficacy of Fosmidomycin and Clindamycin Against Murine Malaria Plasmodium berghei
Walker L.A., Bagonza V., Bobb B., Sullivan D.J.
International Journal for Parasitology: Drugs and Drug Resistance , 2025
19.
SF2312 is a natural phosphonate inhibitor of enolase
Leonard P.G., Satani N., Maxwell D., Lin Y., Hammoudi N., Peng Z., Pisaneschi F., Link T.M., Lee G.R., Sun D., Prasad B.A., Di Francesco M.E., Czako B., Asara J.M., Wang Y.A., et. al.
Nature Chemical Biology , 2016
20.
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues
Pisaneschi, Lin, Leonard, Satani, Yan, Hammoudi, Raghavan, Link, Georgiou, Czako, Muller
Molecules , 2019
21.
Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate
Krucinska J., Lombardo M.N., Erlandsen H., Hazeen A., Duay S.S., Pattis J.G., Robinson V.L., May E.R., Wright D.L.
Scientific Reports , 2019
22.
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Lin Y., Satani N., Hammoudi N., Yan V.C., Barekatain Y., Khadka S., Ackroyd J.J., Georgiou D.K., Pham C., Arthur K., Maxwell D., Peng Z., Leonard P.G., Czako B., Pisaneschi F., et. al.
Nature Metabolism , 2020
23.
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study
Yan V.C., Yang K.L., Ballato E.S., Khadka S., Shrestha P., Arthur K., Georgiou D.K., Washington M., Tran T., Poral A.H., Pham C., Yan M.J., Muller F.L.
ACS Medicinal Chemistry Letters , 2020
24.
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers
Yan V.C., Pham C., Ballato E.S., Yang K.L., Arthur K., Khadka S., Barekatain Y., Shrestha P., Tran T., Poral A.H., Washington M., Raghavan S., Czako B., Pisaneschi F., Lin Y., et. al.
Journal of Medicinal Chemistry , 2022
25.
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration
Yan V.C., Barekatain Y., Lin Y., Satani N., Hammoudi N., Arthur K., Georgiou D.K., Jiang Y., Sun Y., Marszalek J.R., Millward S.W., Muller F.L.
ACS Pharmacology & Translational Science , 2023
26.
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
Milanes J.E., Yan V.C., Pham C., Muller F., Kwain S., Rees K.C., Dominy B.N., Whitehead D.C., Millward S.W., Bolejack M., Shek R., Tillery L., Phan I.Q., Staker B., Moseman E.A., et. al.
PLoS Pathogens , 2024
27.
Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei
Roster C.P., LaVigne D., Milanes J.E., Knight E., Anderson H.D., Pizarro S., Harding E.M., Morris M.T., Yan V.C., Pham C., Muller F., Kwain S., Rees K.C., Dominy B., Whitehead D.C., et. al.
Pathogens , 2023
30.
The Synthesis, Crystal Structure, Modification, and Cytotoxic Activity of α-Hydroxy-Alkylphosphonates
Szalai Z., Kis A.S., Takács A., Kőhidai L., Karaghiosoff K., Czugler M., Drahos L., Keglevich G.
Molecules , 2025
31.
The typical crystal structures of a few representative α-aryl-α-hydroxyphosphonates
Rádai Z., Kiss N.Z., Czugler M., Karaghiosoff K., Keglevich G.
Acta crystallographica. Section C, Structural chemistry , 2019
32.
Synthesis, X-ray crystal structure and antimicrobial activity of phosphorylated derivatives of α-bromocinnamaldehyde
Davletshin R., Andrey S., Ivshin K., Davletshina N., Sokolova E., Zelenikhin P., Baklagina A., Shulaeva M., Gerasimov A., Kuryntseva P.
Journal of Molecular Structure , 2026
34.
Davletshin Rustam Rifkhatovich, Sedov Andrey Nikolaevich, Shulaeva Marina Petrovna, Ivshin Kamil A., Davletshina Natal'ya Victorovna, Gerasimov Alexander Vladimirovich, Kuryntseva Polina Aleksandrovna, Mosunova Sofia Vladimirovna
Mendeleev Communications , 2025
35.
Mechanistic approach for expeditious and solvent-free synthesis of α-hydroxy phosphonates using potassium phosphate as catalyst
37.
Synthesis, Crystal Structure, and Biological Activity of α-Hydroxyphosphonates
Sedov A.N., Davletshin R.R., Davletshina N.V., Ivshin K.A., Fedonin A.P., Osogostok A.R., Shulaeva M.P.
Russian Journal of Organic Chemistry , 2023
38.
Catalysis of the Abramov Reaction under Conditions of Microwave Activation
Davletshin R.R., Sedov A.N., Davletshina N.V., Ivshin K.A., Fedonin A.P., Osogostok A.R., Cherkasov R.A.
Russian Journal of Physical Chemistry A , 2023
40.
The flame retardancy and thermal stability properties of flame-retarded epoxy resins based on α-hydroxyphosphonate cyclotriphosphazene
41.
Thermal behavior of phosphorus derivatives of hydrogenated cardanol
de Sousa Rios M.A., Mazzetto S.E.
Fuel Processing Technology , 2012
42.
Synthesis and in silico / in vitro evaluation of alkyne containing α-hydroxyphosphonate derivatives as potential antibacterial agents
Telu J.R., Kuntala N., Kankanala K., Banothu V., Kapavarapu R., Pal S., Anireddy J.S.
Journal of Molecular Structure , 2025